| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/27/2004 | US6727350 Toso |
| 04/27/2004 | US6727349 Recombinant anti-CCR2 antibodies and methods of use therefor |
| 04/27/2004 | US6727239 Inhibitory activity on no- synthase enzymes producing nitrogen monoxide no and/or an activity which traps the reactive oxygen species (ros) |
| 04/27/2004 | US6727225 TWEAK receptor |
| 04/27/2004 | US6727082 For identifying drugs that inhibit fungal gtpase activity, particularly those involved in cell wall integrity, hyphael formation and other functions critical to pathogenesis; isolated geranylgeranyl protein transferase |
| 04/27/2004 | US6727080 Monoclonal antibodies for use in cancer immunotherapy and their preparation; marker not restricted to previously defined histological classes of cancer |
| 04/27/2004 | US6727062 Identification of target structures E.G. in vivo selection method for a phage library |
| 04/27/2004 | US6726909 Administering antibody |
| 04/27/2004 | CA2152166C Process for detecting fibrocystic desease or a cftr gene mutation |
| 04/27/2004 | CA2058370C Monoclonal antibodies against human tumor necrosis factor .alpha. |
| 04/22/2004 | WO2004033677A2 Secreted acid phosphatase (sapm) is present only in pathogenic mycobacteria and expressed selectively at acidic ph |
| 04/22/2004 | WO2004033675A1 Flavin protein of trypanosoma cruzi, method of screening vermicide with the use of the same and diagnostic |
| 04/22/2004 | WO2004033674A1 Novel endothelial cells, antibodies directed against said cells and use thereof, in particular for screening angiogenesis inhibiting substances |
| 04/22/2004 | WO2004033658A2 Recombinant catalytic polypeptides and their uses |
| 04/22/2004 | WO2004033645A2 Methods of regulating body weight |
| 04/22/2004 | WO2004033630A2 Modified hepsin molecules having a substitute activation sequence and uses thereof |
| 04/22/2004 | WO2004033628A2 Use of monoclonal antibodies to distinguish protein conformational isoforms |
| 04/22/2004 | WO2004033500A1 Peptides modulating caspase activation |
| 04/22/2004 | WO2004033499A1 Cell death-inducing agent |
| 04/22/2004 | WO2004033494A1 Tryptase polypeptide and uses thereof |
| 04/22/2004 | WO2004032966A1 Cell growth regulator |
| 04/22/2004 | WO2004032962A1 Combination therapy with class iii anti-cea monoclonal antibodies and therapeutic agents |
| 04/22/2004 | WO2004032961A1 Bispecific anti-erb-b antibodies and their use in tumor therapy |
| 04/22/2004 | WO2004032960A1 Pharmaceutical compositions directed to erb-b1 receptors |
| 04/22/2004 | WO2004032957A1 Immunization of non-human mammals against streptococcus equi |
| 04/22/2004 | WO2004032877A2 Compositions, organisms and methodologies employing a novel human kinase |
| 04/22/2004 | WO2004032870A2 Methods for treating post-surgical pain by admisnistering a nerve growth factor antagonist and compositions containing the same |
| 04/22/2004 | WO2004032868A2 Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof |
| 04/22/2004 | WO2004032857A2 Antibody therapy |
| 04/22/2004 | WO2004032852A2 Methods for treating cardiac arrhythmia and preventing death due to cardiac arrhythmia using ngf antagonists |
| 04/22/2004 | WO2004032841A2 System for production and screening of monoclonal antibodies |
| 04/22/2004 | WO2004032838A2 Methods for treating cancer by inhibiting wnt signaling |
| 04/22/2004 | WO2004032832A2 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |
| 04/22/2004 | WO2004032831A2 Metalization of microtubules |
| 04/22/2004 | WO2004032829A2 Immunostimulatory compositions and methods of stimulating an immune response |
| 04/22/2004 | WO2004032828A2 Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders |
| 04/22/2004 | WO2004032718A2 Cytokine antagonists for neurological and neuropsychiatric disorders |
| 04/22/2004 | WO2004032711A2 Diagnosis and monitoring of inflammation, ischemia and appendicitis |
| 04/22/2004 | WO2004032622A2 Production of peptides in plants as viral coat protein fusions |
| 04/22/2004 | WO2004032599A2 Novel immunogenic proteins of leptospira |
| 04/22/2004 | WO2003099312A8 Method for determining immune system affecting compounds |
| 04/22/2004 | WO2003086286A3 Treatment of type 1 diabetes before and after expression of predisposition markers |
| 04/22/2004 | WO2003061561A8 Epsilon immunoglobulin chain derived peptides for induction of anti-ige antibodies |
| 04/22/2004 | WO2003055994A9 Hxhv virus, nucleic material, peptide material and uses |
| 04/22/2004 | WO2003052082A3 Fusion partner cells and uses thereof |
| 04/22/2004 | WO2003046565A3 Ig lambda biopolymer markers predictive of alzheimers disease |
| 04/22/2004 | WO2003040345A3 Type 2 cytokine receptor and nucleic acids encoding same |
| 04/22/2004 | WO2003039346A8 Diagnostics and therapeutics for ocular abnormalities |
| 04/22/2004 | WO2003027248A8 Antibody inhibitors of gdf-8 and uses thereof |
| 04/22/2004 | WO2002100897A3 Brca1/acc alpha molecular complexes, diagnostic and therapeutic applications |
| 04/22/2004 | WO2002100148A3 Treatment or prophylaxis of insulin-producing cell graft rejection |
| 04/22/2004 | WO2002098362A3 Use of rank antagonists to treat cancer |
| 04/22/2004 | WO2002094852A8 Taci-immunoglobulin fusion proteins |
| 04/22/2004 | WO2002092782A3 Diagnosis and treatment of malignant neoplasms |
| 04/22/2004 | WO2002092017A8 Human antipneumococcal antibodies from non-human animals |
| 04/22/2004 | WO2002064731A9 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 04/22/2004 | WO1991007986A8 Method of treating septic shock |
| 04/22/2004 | WO1990013281A3 Method of suppressing hiv infection |
| 04/22/2004 | US20040078833 Mutations in and genomic structure of herg - along QT syndrome gene |
| 04/22/2004 | US20040078148 Site-directed mutagenesis; green fluorescent proteins; fusion proteins |
| 04/22/2004 | US20040077844 Spheres are functionalized in a controlled manner to enable covalent linkages of ligands |
| 04/22/2004 | US20040077843 Antibody/receptor targeting moiety for enhanced delivery of armed ligand |
| 04/22/2004 | US20040077842 First antigen recognition portion that binds a C3b-like receptor and a second that binds an antigenic molecule present in the circulatory system |
| 04/22/2004 | US20040077841 Probes for identifying cancer-specific antigens |
| 04/22/2004 | US20040077840 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroups B epitopes |
| 04/22/2004 | US20040077837 Microtubule-associated proteins and tubulins |
| 04/22/2004 | US20040077544 Specific interference with alpha 5 beta 1 integrin and fibronectin binding |
| 04/22/2004 | US20040077536 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof |
| 04/22/2004 | US20040077534 Methods and compositions for the treatment and prevention of Staphylococcus a ureus infections |
| 04/22/2004 | US20040077532 Aglyco products and methods of use |
| 04/22/2004 | US20040077526 SR-BI antagonist and use thereof as contraceptives and in the treatment of steroidal overproduction |
| 04/22/2004 | US20040077081 G250 antibodies are capable of eliciting a delayed immune response in cancer therapy, in the treatment of renal cell carcinoma and for the treatment of metastases after tumor surgery |
| 04/22/2004 | US20040077064 Identification and isolation of novel DNA and to the recombinant production of novel polypeptides |
| 04/22/2004 | US20040077051 LSR receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
| 04/22/2004 | US20040077049 For preventing, ameliorating, disorders or diseases including cancer, peripheral and central nervous system disorders, genitourinary disorders, cardiovascular disorders, and Chronic obstructive pulmonary (or airways) disease (COPD) |
| 04/22/2004 | US20040077046 Histone deacetylase-related gene and protein |
| 04/22/2004 | US20040077045 Melanoma Associated antigen (MAGE) tumor associated genes, nucleic acids encoding such peptides and antibodies relating thereto; Human Leukocyte Antigen (HLA) |
| 04/22/2004 | US20040077027 Detecting an increased risk of heart failure in a subject by detecting an increased level of urotensin II in a bodily fluid sample from a subject |
| 04/22/2004 | US20040077021 Haptens, intermediates, and immunogens that are useful in the production of antibodies specific for the methylenedioxy class of amphetamine derivatives |
| 04/22/2004 | US20040077009 Human cyclin-dependent kinase (hPNQALRE) |
| 04/22/2004 | US20040077007 Human SMN-like protein |
| 04/22/2004 | US20040077000 Using cynomologous monkey P-glycoprotein nucleic acids and polypeptides in determining bioavailability of drugs and for screening for inhibitors of cynomologous P-glycoprotein |
| 04/22/2004 | US20040076997 Determining the risk of metastasis of a breast or colon tumor, which involve determining whether a tissue sample from a tumor expresses a polypeptide encoded by a gene SEQ ID NOS:1-18 |
| 04/22/2004 | US20040076992 Novel cell adhesion molecule specific to activated leukocyte |
| 04/22/2004 | US20040076991 Modified interleukin-1 receptor antagonist(il-1ra) with reduced immunogenicity |
| 04/22/2004 | US20040076955 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| 04/22/2004 | US20040076951 Also antibodies, gene chips, transgenic non-human animals |
| 04/22/2004 | US20040076644 Immunogenic preparation that is recognized as a specific monoclonal antibody and a veterinarily acceptable vehicle or excipient |
| 04/22/2004 | US20040076636 HIV immunogenic complexes |
| 04/22/2004 | US20040076632 DNA vaccine against feline immunodeficiency virus |
| 04/22/2004 | US20040076631 Treating infections caused by respiratory syncytial virus, transfected eukaryotic cells, isolating human B cells from transfected mouse, use for immunoassay, diagnosis the virus, test kits |
| 04/22/2004 | US20040076630 Method for creating antigens using Emus |
| 04/22/2004 | US20040076629 Polypeptide with 46 kDalton HMFG differentiation antigen binding specificity and clotting factors V and VIII light-chain homologies, fusion protein, polynucleotide and polyribonucleotide encoding the polypeptide, anti-polypeptide antibodies, kits and methods of use thereof |
| 04/22/2004 | US20040076628 Use of IL-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 04/22/2004 | US20040076627 Humanised antibodies |
| 04/22/2004 | US20040076626 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L |
| 04/22/2004 | US20040076625 A fusion proteins comprising self or non-self antigens, is used for treatment and prevention of immunoglobulin E related diseases, gene expression |
| 04/22/2004 | US20040076611 Molecular antigen arrays |
| 04/22/2004 | US20040076608 Cytokine uses; compositions; methods |
| 04/22/2004 | US20040076607 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |